321
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Prophylactic treatment for preeclampsia in high-risk teenage primigravidae with nitric oxide donors: a pilot study

, , , &
Pages 2617-2620 | Received 17 Aug 2015, Accepted 13 Sep 2015, Published online: 12 Oct 2015

References

  • Walker JJ. Pre-eclampsia. Lancet 2000;356:1260–5
  • Campbell S, Bewley S, Cohen-Overbrook T. Investigation of the utroplacental circulation by Doppler ultrasound. Semin Perinatol 1987;11:362–8
  • Bolte AC, Dekker GA. Uterine artery Doppler as screening tool for pre-eclampsia. In: Wildschut HJ, Weiner CP, eds. When to screen in obstetrics and gynecology. Philadelphia: Saunders Elsevier; 2006:408–19
  • Albaiges G, Missfelder-Lobos H, Lees C, et al. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000;96:559–64
  • Papageorghiou AT, Roberts N. Uterine artery Doppler screening for adverse pregnancy outcome. Curr Opin Obstet Gynecol 2005;17:584–90
  • Hofmeyr GJ, Duley L, Atallah A. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. BJOG 2007;114:933–43
  • Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2010;CD001059
  • Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 2008;CD004227
  • Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007;369:1791–8
  • Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007;CD004659
  • Lopez-Jaramillo P, Arenas WD, Garcia RG, et al. The role of L-arginine-nitric oxide pathway in pre-eclampsia. Ther Adv Cardiovasc Dis 2008;2:261–75
  • Wimalawansa SJ. Nitric oxide: new evidence for novel therapeutic indications. Expert Opin Pharmacother 2008;9:1935–54
  • de Pace V, Chiossi G, Facchinetti F. Clinical use of nitric oxide donors and l-arginine in obstetrics. J Matern Fetal Neonatal Med 2007;20:569–79
  • Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892–8
  • Chien PF, Arnott N, Gordon A, et al. How useful is uterine artery Doppler flow velocimetry in the prediction of preeclampsia, intrauterine growth retardation and perinatal death? An overview. BJOG 2000;107:196–208
  • Yu CK, Papageorghiou AT, Parra M, et al. Fetal Medicine Foundation Second Trimester Screening Group. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol 2003;22:233–9
  • Kublickiene KR, Nissel H, Poston L, et al. Modulation of vascular tone by nitric oxide and endothelin 1 in myometrial resistance arteries from pregnant women at term. Am J Obstet Gynecol 2000;182:87–93
  • Storment JM, Meyer M, Osol G. Estrogen augments the vasodilatory effects of vascular endothelial growth factor in the uterine circulation of the rat. Am J Obstet Gynecol 2000;183:449–53
  • Moncada S. The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway. Acta Physiol Scand 1992;145:201–27
  • Longo M, Jain V, Vedernikov YP, et al. Effect of nitric oxide and carbon monoxide on uterine contractility during human and rat pregnancy. Am J Obstet Gynecol 1999;181:981–8
  • Morris NH, Eaton BM, Dekker G. Nitric oxide, the endothelium, pregnancy and pre-eclampsia. Br J Obstet Gynaecol 1996;103:4–15
  • Meher S, Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007;CD006490
  • Johal T, Lees CC, Everett TR, Wilkinson IB. The nitric oxide pathway and possible therapeutic options in pre-eclampsia. Br J Clin Pharmacol 2014;78:244–57
  • Schleussner E, Lehmann T, Kahler C, et al. Impact of the nitric oxide–donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial. J Perinat Med 2014;42:507–14
  • Kalidindi M, Velauthar L, Khan K, Aquilina J. The role of nitrates in the prevention of pre-eclampsia: an update. Curr Opin Obstet Gynecol 2012;24:361–7
  • Nakatsuka M, Takata M, Tada K, et al. A long-term transdermal nitric oxide donor improves utero-placental circulation in women with preeclampsia. J Ultrasound Med 2002;21:831–6
  • Germain AM, Valdes G, Romanik MC, Reyes MS. Evidence supporting a beneficial role for long-term l-arginine supplementation in high risk pregnancies. Hypertension 2004;44:e l
  • Rytlewski K, Olszanecki R, Korbut R, Zdebski Z. Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest 2005;35:32–7
  • Leszczyńska-Gorzelak B, Laskowska M, Marciniak B, Oleszczuk J. The use of nitroglycerin as nitric oxide donor for treatment of preterm labor. Ginekol Pol 2002;73:666–71
  • Pullen KM, Riley ET, Waller SA, et al. Randomized comparison of intravenous terbutaline vs nitroglycerin for acute intrapartum fetal resuscitation. Am J Obstet Gynecol 2007;197:414–16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.